1194057-62-9 Usage
Description
(2S,4R)-2-hydroxyMethyl-4-CBZ-aMino Pyrrolidine-HCl, with the molecular formula C13H21ClN2O3, is a hydrochloride salt of an amino pyrrolidine compound. It features a hydroxymethyl group and a carbobenzyloxy (CBZ) functional group attached to the amino group. This chiral compound serves as a potential intermediate in the synthesis of various pharmaceuticals and is widely utilized in organic chemistry research and drug development. It also demonstrates potential as a chiral building block in the creation of biologically active molecules. (2S,4R)-2-hydroxyMethyl-4-CBZ-aMino Pyrrolidine-HCl exhibits moderate solubility in water and can be stored at room temperature.
Uses
Used in Pharmaceutical Industry:
(2S,4R)-2-hydroxyMethyl-4-CBZ-aMino Pyrrolidine-HCl is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Organic Chemistry Research:
In the field of organic chemistry, (2S,4R)-2-hydroxyMethyl-4-CBZ-aMino Pyrrolidine-HCl is employed as a chiral building block, facilitating the synthesis of biologically active molecules with potential applications in medicine and other areas.
Used in Drug Development:
(2S,4R)-2-hydroxyMethyl-4-CBZ-aMino Pyrrolidine-HCl is utilized in drug development for its potential to enhance the properties of new drug candidates, contributing to improved efficacy and selectivity in targeted therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1194057-62-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,4,0,5 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1194057-62:
(9*1)+(8*1)+(7*9)+(6*4)+(5*0)+(4*5)+(3*7)+(2*6)+(1*2)=159
159 % 10 = 9
So 1194057-62-9 is a valid CAS Registry Number.
1194057-62-9Relevant articles and documents
ANTIBACTERIAL FLUOROQUINOLONE ANALOGS
-
Page/Page column 125-126, (2010/01/29)
Compounds having antibacterial activity are disclosed. The compunds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, D, E, G, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.